Anti-Aggregative Therapy and Laser Iridectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE4

Study Classification

INTERVENTIONAL

Study Start Date

2006-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Our study investigates the effect of anti-aggregative treatment on success and complications of laser iridectomy. The study includes patients scheduled for laser iridectomy due to narrow angles.Patients will undergo first laser treatment with the anti-aggregative treatment and will scheduled for next lase in the other eye after discontinuing the anti-aggregative treatment. The patients will be followed-up for 3 months.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Laser Iridotomy Versus Surgical Iridectomy in Early Angle Closure

NCT01468103

Intraocular Pressure Changes Peripheral Anterior Synechiae Increasing

UNKNOWN NA

Titanium-Sapphire Laser Trabeculoplasty in Glaucoma: A Randomized Study Comparing Titanium-Sapphire With Argon Laser Trabeculoplasty in Open-Angle Glaucoma Patients

NCT00470964

Glaucoma, Open-Angle

COMPLETED NA

EXTERNAL SLT Treatment in Patients With Uncontrolled OPEN ANGLE GLAUCOMA

NCT01384149

Primary Open Angle Glaucoma

COMPLETED PHASE1

Combined Phacoemulsification and Diode Laser Therapy in Chronic Angle Closure Glaucoma

NCT05576493

Angle Closure Glaucoma

UNKNOWN NA

Sequential Laser Iridotomy Using Argon and Q-Switched 532 nm Frequency Doubled Neodymium Yag Laser: A Pilot Study

NCT00452998

Chronic Angle Closure Glaucoma Primary Angle Closure Primary Angle Closure Suspect +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Eyes With Narrow Angle

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The cessation of anti-aggregative treatment for 10 days

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with narrow angle that need laser iridectomy and take anti- aggregative treatment
* over 20 years old
* patients who can stop their anti-aggregative treatment for 10 days